Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Fanconi Anemia 1

Interventions

Cyclophosphamide 47fludarabine phosphate 46Peripheral Blood Stem Cell Transplantation 36Tacrolimus 34Antilymphocyte Serum 33Busulfan 32Mycophenolic Acid 31Filgrastim 24Cyclosporine 24Radiotherapy 22Methotrexate 20Whole-Body Irradiation 18Methylprednisolone 18Melphalan 18Cord Blood Stem Cell Transplantation 14fludarabine 12Etoposide 11Granulocyte Colony-Stimulating Factor 8sargramostim 7Alemtuzumab 7Sirolimus 6Psychiatric Rehabilitation 6Flow Cytometry 6Cytarabine 6Rituximab 4Prednisone 4Polymerase Chain Reaction 4Immunologic Techniques 4thymoglobulin 3Thiotepa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Chromatography × Myeloid × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡